C
DexCom, Inc. DXCM
$79.28 -$1.49-1.85% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 25.30% -28.01% -40.81% 11.52% 23.81%
Total Depreciation and Amortization 20.92% 14.29% 7.97% 14.73% 19.22%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 133.33% 306.90% 3.61% 90.11% 200.62%
Change in Net Operating Assets -66.86% -97.89% 102.48% -90.31% 44.44%
Cash from Operations 8.45% -12.14% 125.60% -25.89% 46.82%
Capital Expenditure -42.36% -52.90% -137.33% -120.63% -12.03%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 124.84% 42.14% -138.32% 349.03% 75.29%
Cash from Investing 66.33% 33.96% -173.20% 217.16% 66.02%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -- 5.97% -- 3.50% --
Repurchase of Common Stock -- -- 100.00% -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -21.43% 80.46% -132.65% -8.33% 98.63%
Cash from Financing -21.43% 165.96% 99.75% -15.55% -100.15%
Foreign Exchange rate Adjustments 1,750.00% 160.53% -283.61% 345.71% 54.55%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 188.54% 4.88% 80.47% 42.29% -84.59%